Actively Recruiting
Self-sampling for Non-attenders to Cervical Cancer Screening
Led by The Institute of Molecular and Translational Medicine, Czech Republic · Updated on 2026-03-23
15000
Participants Needed
1
Research Sites
375 weeks
Total Duration
On this page
Sponsors
T
The Institute of Molecular and Translational Medicine, Czech Republic
Lead Sponsor
N
National Institute for Cancer Research, Czech Republic
Collaborating Sponsor
AI-Summary
What this Trial Is About
The trial will evaluate whether self-sampling and human papillomavirus (HPV) testing may increase cervical cancer screening attendance among under-screened women in Czech Republic. Different ways of offering self-sampling device will be evaluated.
CONDITIONS
Official Title
Self-sampling for Non-attenders to Cervical Cancer Screening
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Women aged 30 to 65 years; women over 65 years allowed for Arm A
- Women living in the Czech Republic
- Women who have not participated in cervical cancer screening in the Czech Republic for at least 3 years (for Arms B and C)
- Women who have completed informed consent
- Women capable of performing cervicovaginal self-sampling
You will not qualify if you...
- Pregnant women
- Women who have never had sexual intercourse
- Women who have had a hysterectomy including removal of the cervix
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University Hospital Olomouc
Olomouc, Czechia
Actively Recruiting
Research Team
M
Marian Hajduch, MD, PhD.
CONTACT
V
Vladimira Koudelakova, MSc, Ph.D.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
SCREENING
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here